Alpa Laboratories
ALPA •NSE

Alpa Laboratories

₹57.410.83 (1.47%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
56.57
Today’s high
57.95
52 week low
46.10
52 week high
92.50
Open price
56.58
Previous close
56.58
Live volume
7,290
Lower circuit
45.27
Upper circuit
67.89

Fundamentals

Market Cap
₹118Cr
ROE
8.06%
P/E Ratio(TTM)
29.04
EPS(TTM)
1.93
P/B Ratio
0.63
Dividend Yield
0.00%
Industry P/E
40.71
Book Value
88.53
Debt to Equity
0.01
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
JUN '26
₹29.70Cr
-4.93%
₹0.98Cr
-28.99%
010203040
Jun '25
Sep '25
Dec '25
Mar '26
Jun '26
Revenue growthValue
1Y (TTM)-4%
3Y CAGR+6%
Profit growthValue
1Y (TTM)-92%
3Y CAGR+6%

About

Alpa Laboratories Limited is a global pharmaceutical firm committed to improving health outcomes for patients around the world by manufacturing best-quality medicines. The company makes substantial investments in branded generic products, leveraging its specialized knowledge to expand its footprint in critical markets across the globe. Its strong financial position enables the organization to fund innovative solutions that are specifically designed to address the evolving needs of patients. A core part of its mission, established since 1988, is to continuously enhance operational performance to successfully introduce new and effective medicines. The company's philosophy prioritizes long-term sustainable growth and creating lasting value by emphasizing transparency, accountability, and integrity in all operations. Reflecting its successful strategy, the company achieved a notable 20.70% growth in standalone total income in the most recent financial year.;
CEO/MD
Paresh Chawla
Founded in
1988
NSE symbol
ALPA
Industry

Shareholding pattern

Sep '25
Dec '25
Mar '26
Jun '26
Sep '26
Shareholder details

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
₹2,520.30
+17.80 (0.71%)
L
    H
    19,010.9128.045.64
    PfizerPFIZER
    ₹3,893.30
    -24.60 (0.63%)
    L
      H
      17,930.5920.864.09
      ₹6,507.00
      -7.50 (0.12%)
      L
        H
        16,280.5091.6118.52
        Natco PharmaNATCOPHARM
        ₹808.95
        +4.60 (0.57%)
        L
          H
          15,772.8813.781.5
          2026
          14
          Nov
          Quarterly Result
          Upcoming
          Release date
          14
          Aug
          Quarterly Result
          Release date
          29
          May
          Annual Result
          Release date
          11
          Feb
          Quarterly Result
          Release date
          2025
          14
          Nov
          Quarterly Result
          Release date
          13
          Aug
          Quarterly Result
          Release date
          Events calendar
          View upcoming events in other stocks